These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 15283939

  • 1. A comparison of the central effects of different progestins used in hormone replacement therapy.
    Cagnacci A, Arangino S, Baldassari F, Alessandrini C, Landi S, Volpe A.
    Maturitas; 2004 Aug 20; 48(4):456-62. PubMed ID: 15283939
    [Abstract] [Full Text] [Related]

  • 2. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 20; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 3. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H, Odabasi AR, Demircan S, Köseoğlu K, Kizilkaya K, Onur E.
    Gynecol Endocrinol; 2007 Feb 20; 23(2):99-104. PubMed ID: 17454160
    [Abstract] [Full Text] [Related]

  • 4. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
    Perrone G, Falaschi P, Capri O, Pastore R, Galoppi P, D'Urso R, Martocchia A, Anelli G, Zichella L.
    Int J Fertil Menopausal Stud; 1994 Feb 20; 39(4):202-7. PubMed ID: 7951402
    [Abstract] [Full Text] [Related]

  • 5. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec 20; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 6. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
    Pedersen NG, Pedersen SH, Dalsgaard T, Lund CO, Nilas L, Ottesen B.
    Maturitas; 2004 Dec 10; 49(4):304-14. PubMed ID: 15531126
    [Abstract] [Full Text] [Related]

  • 7. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA, Liu JH, Speroff L, Shumel BS, Symons JP.
    Am J Obstet Gynecol; 2003 Jan 10; 188(1):92-9. PubMed ID: 12548201
    [Abstract] [Full Text] [Related]

  • 8. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 10; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 9. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
    Taner MZ, Ozpolat E, Taskiran C, Onan MA, Gursel T, Karabulut E, Gursoy R, Himmetoglu O.
    Maturitas; 2006 Feb 20; 53(3):267-73. PubMed ID: 15978753
    [Abstract] [Full Text] [Related]

  • 10. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
    Demir B, Ozturkoglu E, Solaroglu A, Baskan B, Kandemir O, Karabulut E, Haberal A.
    Gynecol Endocrinol; 2008 Jun 20; 24(6):347-53. PubMed ID: 18584415
    [Abstract] [Full Text] [Related]

  • 11. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Jun 20; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 12. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H, Odabaşi AR, Demircan S, Karul A, Kozaci LD, Köseoğlu K, Kizilkaya K, Başak O.
    Gynecol Endocrinol; 2006 Jul 20; 22(7):381-7. PubMed ID: 16864148
    [Abstract] [Full Text] [Related]

  • 13. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
    Illouz S, Dales JP, Sferlazzo K, Garcia S, Carpentier-Meunier S, Boubli L, Lavaut MN, Charpin C.
    Int J Mol Med; 2003 Oct 20; 12(4):517-23. PubMed ID: 12964029
    [Abstract] [Full Text] [Related]

  • 14. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study.
    Thromb Haemost; 1996 Mar 20; 75(3):476-80. PubMed ID: 8701411
    [Abstract] [Full Text] [Related]

  • 15. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F, Terek MC, Karadadaş N, Bilgin O.
    J Reprod Med; 2001 Nov 20; 46(11):962-8. PubMed ID: 11762152
    [Abstract] [Full Text] [Related]

  • 16. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
    Castelo-Branco C, Casals E, Sanllehy C, Duran M, Fortuny A, Vanrell JA.
    J Reprod Med; 1996 Nov 20; 41(11):833-8. PubMed ID: 8951134
    [Abstract] [Full Text] [Related]

  • 17. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H, Haapalahti P, Tuomikoski P, Viitasalo M, Väänänen H, Sovijärvi AR, Ylikorkala O, Mikkola TS.
    Menopause; 2012 Jan 20; 19(1):82-8. PubMed ID: 21934534
    [Abstract] [Full Text] [Related]

  • 18. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 19. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M.
    Maturitas; 2007 Jun 20; 57(2):171-81. PubMed ID: 17317046
    [Abstract] [Full Text] [Related]

  • 20. The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial.
    Liu JH, Muse KN.
    Am J Obstet Gynecol; 2005 Apr 20; 192(4):1316-23; discussion 1323-4. PubMed ID: 15846228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.